Financial Advisors Eli Lilly’s tirzepatide injection results could trigger another bull run: Here’s why August 1, 2024 by Eli Lily’s Tirzepatide results have the potential to start a new bull run in the stock, which was in a downtrend near a key support level. Share: Share on: 0